SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Shree Ganesh Remedies informs about outcome of board meeting

03 May 2021 Evaluate

Pursuant to Regulation 33 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Listing Regulations) read with Schedule III to the said Regulations, Shree Ganesh Remedies has informed that the Board of Directors of the Company, at its Meeting held today, i.e., on Monday, May 03, 2021 (which commenced at 1l.00 a.m. and concluded at 11:45 am.), have approved/ noted the following: Audited Financial Results for the quarter and Financial year ended March 31, 2021, and recommendation of Final Dividend for the Financial Year 2020-21.

The above information is a part of company’s filings submitted to BSE.

Shree Ganesh Remed. Share Price

536.00 2.10 (0.39%)
20-Apr-2026 14:26 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1670.85
Dr. Reddys Lab 1236.40
Cipla 1233.10
Zydus Lifesciences 937.40
Lupin 2329.40
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×